Wrangling Regulators Leave India Foreign Drug-Investment Limit In Doubt
This article was originally published in PharmAsia News
Executive Summary
The Competition Commission of India missed an April 1 deadline to regulate foreign direct investments in the local pharmaceutical industry, leaving unresolved the issue of a 74% limit on ownership stakes.